» Articles » PMID: 2950274

Isolation and Structural Analysis of the Circulating Human Cardiodilatin (alpha ANP)

Overview
Journal Klin Wochenschr
Specialty General Medicine
Date 1986 Dec 15
PMID 2950274
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

A new method was applied to isolate a polypeptide hormone from human blood. The polypeptides from 1,000 1 of hemofiltrate with a molecular weight lower than 20 kDaltons were adsorbed to 2.5 kg alginic acid, then eluted, precipitated, and desalted on a G-25 Sephadex column, thus obtaining a crude lyophilised plasma polypeptide extract. These polypeptides were further submitted to ion-exchange chromatography. Thereafter, two steps of HPLC were carried out to purify a distinct polypeptide which was the circulating form of cardiodilatin (CDD) in this case. The amino acid analysis, C-terminal enzymatic cleavage by carboxypeptidase A, and sequence analysis showed that the only form of circulating cardiodilatin is the 28 amino acid residue containing molecule, cardiodilatin-99-126 cleaved from the C-terminus of cardiodilatin-126 and identical with alpha-ANP (alpha atrial natriuretic polypeptide). Other bioactive molecular forms of the polypeptide hormones of the cardiodilatin family were not detected in the hemofiltrate. The isolation procedure was followed up by a bioassay using in vitro vascular smooth muscle relaxation.

Citing Articles

Liquid chromatography and electrospray mass spectrometric mapping of peptides from human plasma filtrate.

Raida M, Schulz-Knappe P, Heine G, Forssmann W J Am Soc Mass Spectrom. 1999; 10(1):45-54.

PMID: 9888184 DOI: 10.1016/S1044-0305(98)00117-2.


The dihydropyridine calcium channel blocker BAY t 7207 attenuates the exercise induced increase in plasma ANF and cyclic GMP in patients with mildly impaired left ventricular function.

Kentsch M, Otter W, Drummer C, Peinke V, Theisen K, Muller-Esch G Eur J Clin Pharmacol. 1995; 49(3):177-82.

PMID: 8665993 DOI: 10.1007/BF00192377.


Treatment of acute postoperative renal failure after liver and heart transplantation by urodilatin.

Cedidi C, Kuse E, Meyer M, Oldhafer K, Ringe B, Wahlers T Clin Investig. 1993; 71(6):435-6.

PMID: 8353401 DOI: 10.1007/BF00180055.


Presence of immunoreactive atrial natriuretic peptide in nerve fibres and conduction cells in the conduction system of the bovine heart.

Hansson M, Forsgren S Anat Embryol (Berl). 1993; 188(4):331-7.

PMID: 8279697 DOI: 10.1007/BF00185942.


Localization of the bronchodilator effect induced by type A natriuretic peptide in asthmatic subjects.

Fluge T, FABEL H, Wagner T, Forssmann W Clin Investig. 1994; 72(10):772-4.

PMID: 7865980 DOI: 10.1007/BF00180545.


References
1.
Yamaji T, Ishibashi M, Takaku F . Atrial natriuretic factor in human blood. J Clin Invest. 1985; 76(4):1705-9. PMC: 424170. DOI: 10.1172/JCI112159. View

2.
Flynn T, de Bold M, de Bold A . The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Commun. 1983; 117(3):859-65. DOI: 10.1016/0006-291x(83)91675-3. View

3.
Hock D, Schriek U, Fey E, Forssmann W, Mutt V . Isolation of bovine cardiodilatin by fast protein liquid chromatography and reversed-phase high-performance liquid chromatography. J Chromatogr. 1987; 397:347-53. DOI: 10.1016/s0021-9673(01)85018-4. View

4.
Forssmann W . Cardiac hormones. I. Review on the morphology, biochemistry, and molecular biology of the endocrine heart. Eur J Clin Invest. 1986; 16(6):439-51. DOI: 10.1111/j.1365-2362.1986.tb02159.x. View

5.
Schwartz D, GELLER D, Manning P, Siegel N, Fok K, Smith C . Ser-Leu-Arg-Arg-atriopeptin III: the major circulating form of atrial peptide. Science. 1985; 229(4711):397-400. DOI: 10.1126/science.3160114. View